Immunogenicity and Safety of Different Dosing Schedules of Trivalent Influenza Vaccine in HIV-infected Pregnant Women

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2012
The overall aim of this project is to evaluate the safety and immunogenicity of 3 different dosing options of trivalent influenza vaccine (TIV) vaccination of HIV-infected pregnant women: single dose, double dose (at same time point) and two-doses (1 month apart).
Epistemonikos ID: 3c8099ab1764ceb326651af7ce2dbf3e313f4572
First added on: May 10, 2024